Skip to main content
Canadian Journal of Public Health = Revue Canadienne de Santé Publique logoLink to Canadian Journal of Public Health = Revue Canadienne de Santé Publique
. 2017 Sep 1;108(5-6):e516–e522. doi: 10.17269/CJPH.108.5955

Prevalence of problematic cannabis use in Canada: Cross-sectional findings from the 2013 Canadian Tobacco, Alcohol and Drugs Survey

Cesar Leos-Toro 110, Vicki Rynard 210, David Hammond 110,
PMCID: PMC6972268  PMID: 29356658

Abstract

OBJECTIVES: Cannabis is the most widely used illicit substance in Canada. There exist a variety of tools to measure problematic characteristics of cannabis use; however, there is no consensus on the operational definition of “problematic use”. The current study sought to estimate the prevalence of problematic cannabis use in Canada, in terms of the kinds of problems Canadians report due to their cannabis use, the levels of harm associated with cannabis consumption, and potential differences among socio-demographic groups.

METHODS: Cross-sectional, nationally representative data for Canadians were obtained from the publicly available Statistics Canada’s 2013 Canadian Tobacco, Alcohol and Drugs Survey (CTADS) (n = 13 635). Binary logistic regression analyses were conducted to examine subgroup differences in patterns of cannabis use and problematic outcomes defined by the World Health Organization’s Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) tool embedded in CTADS.

RESULTS: The findings indicate that, while 1 in 10 Canadians reported using cannabis in the past 3 months, only 2% of the sample of Canadians who reported using cannabis in the past 3 months were characterized as having a “high risk” of severe health or other problems. Canadian male respondents were more likely to report social problems than females and to be categorized as high risk. Youth and young adults between the ages of 15 and 29 consistently reported a greater prevalence of problems associated with their cannabis consumption than their older counterparts.

CONCLUSION: A very small proportion of Canadians report using cannabis to a degree that is problematic. Approximately one in two young people reported using cannabis at some point in their lives, of concern given the negative health outcomes of early cannabis use. This study highlights the need for the development of more sensitive instruments to detect problematic cannabis use.

Key words: Cannabis, marijuana, ASSIST, problematic use, dependence, men’s health, youth, surveillance

Footnotes

Funding acknowledgement: Support was provided by a CIHR New Investigator Award (DH), and a CIHR Public Health Agency of Canada Chair in Applied Public Health (DH).

Conflict of Interest: None to declare.

References

  • 1.United Nations Office of DrugsCrime Vienna. World Drug Report 2015. New York, NY: United Nations Office of Drugs and Crime Vienna; 2015. [Google Scholar]
  • 2.Health Canada. Canadian Tobacco, Alcohol and Drugs Survey - Detailed Tables for 2013. Ottawa, ON: Health Canada; 2015. [Google Scholar]
  • 3.Health Canada. Canadian Alcohol and Drug Use Survey Highlights Report 2008–2011. Ottawa, ON: Health Canada; 2014. [Google Scholar]
  • 4.National Academies of Sciences, Engineering,Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017. [PubMed] [Google Scholar]
  • 5.Filbey FM, Asian S, Calhoun VD, Spence JS, Damaraju E, Caprihan A, et al. Long-term effects of marijuana use on the brain. Proc Natl Acad Sci USA. 2014;111(47):16913–18. doi: 10.1073/pnas.1415297111. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Wrege J, Schmidt A, Walter A, Smieskova R, Bendfeldt K, Radue E-W, et al. Effects of cannabis on impulsivity: A systematic review of neuroimaging findings. Curr Pharm Des. 2014;2013:2126–37. doi: 10.2174/13816128113199990428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.George T, Vaccarino F. Substance Abuse in Canada: The Effects of Cannabis Use During Adolescence. Ottawa, ON: Canadian Centre on Substance Abuse; 2015. [Google Scholar]
  • 8.Lopez-Quintero C, Cobos JPDL, Hasin DS, Okuda M, Wang S, Grant BF, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: Results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Drug Alcohol Depend. 2011;115(1-2):120–30. doi: 10.1016/j.drugalcdep.2010.11.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Beck F, Legleye S. Measuring Cannabis Related Problems and Dependence at the Population Level. Lisbon, Portugal: European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); 2008. [Google Scholar]
  • 10.Lev-Ran S, Le Strat Y, Imtiaz S, Rehm J, Le Foil B. Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: Results from a large representative sample. Am J Addict. 2013;221:7–13. doi: 10.1111/j.1521-0391.2013.00321.x. [DOI] [PubMed] [Google Scholar]
  • 11.Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219–27. doi: 10.1056/NEJMra1402309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Casajuana C, López-Pelayo H, Balcells MM, Miquel L, Colom J, Gual A. Definitions of risky and problematic cannabis use: A systematic review. Subst Use Misuse. 2016;51(13):1760–70. doi: 10.1080/10826084.2016.1197266. [DOI] [PubMed] [Google Scholar]
  • 13.Annaheim B, Rehm J, Gmel G. How to screen for problematic cannabis use in population surveys. Eur Addict Res. 2008;144:190–97. doi: 10.1159/000141643. [DOI] [PubMed] [Google Scholar]
  • 14.Piontek D, Kraus L, Klempova D. Short scales to assess cannabis-related problems: A review of psychometric properties. Subst Abuse Treat Prev Policy. 2008;3:25. doi: 10.1186/1747-597X-3-25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fischer B, Imtiaz S, Rudzinski K, Rehm J. Crude estimates of cannabis-attributable mortality and morbidity in Canada - implications for public health focused intervention priorities. J Public Health. 2015;381:183–88. doi: 10.1093/pubmed/fdv005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Centre for AddictionMental Health. Cannabis Policy Framework. Toronto, ON: CAMH; 2014. [Google Scholar]
  • 17.Management of Substance Abuse: The ASSIST project - Alcohol, Smoking and Substance Involvement Test [homepage on the Internet]. Geneva, Switzerland: World Health Organization, 2015. Available at: http://www.who.int/substance_abuse/activities/assist/en/ (Accessed August 5, 2015).
  • 18.WHO ASSIST Working Group. The Alcohol Smoking and Substance Involvement Screening Test (ASSIST): Development, reliability and feasibility. Addiction. 2002;97(9):1183–94. doi: 10.1046/j.1360-0443.2002.00185.x. [DOI] [PubMed] [Google Scholar]
  • 19.Humeniuk RE, Ali RA, Babor TF, Farrell M, Formigioni ML, Jittiwutikam J, et al. Validation of the Alcohol Smoking and Substance Involvement Screening Test (ASSIST) Addiction. 2008;1036:1039–47. doi: 10.1111/j.1360-0443.2007.02114.x. [DOI] [PubMed] [Google Scholar]
  • 20.Statistics Canada. Summary of Changes Over Time - Canadian Tobacco, Alcohol and Drugs Survey. 2013. [Google Scholar]
  • 21.Statistics Canada. Canadian Tobacco, Alcohol, and Drugs Survey. 2013. [Google Scholar]
  • 22.Statistics Canada. Microdata User Guide: Canadian Tobacco, Alcohol & Drug Survey - Annual February-December 2013. Ottawa, ON: Statistics Canada; 2015. [Google Scholar]
  • 23.Grohol JM. DSM-5 Changes: Addiction, Substance-Related Disorders & Alcoholism. Boston, MA: PsychCentral; 2013. [Google Scholar]
  • 24.López-Pelayo H, Batalla A, Balcells MM, Colom J, Gual A. Assessment of cannabis use disorders: A systematic review of screening and diagnostic instruments. Psychol Med. 2015;456:1121–33. doi: 10.1017/S0033291714002463. [DOI] [PubMed] [Google Scholar]
  • 25.Zeisser C, Thompson K, Stockwell T, Duff C, Chow C, Vallance K, et al. A ‘standard Joint’? The role of quantity in predicting cannabis-related problems. J Addict Res Theory. 2012;20:82–92. doi: 10.3109/16066359.2011.569101. [DOI] [Google Scholar]
  • 26.Danielsson AK, Falkstedt D, Hemmingsson T, Allebeck P, Agardh E. Cannabis use among Swedish men in adolescence and the risk of adverse life course outcomes: Results from a 20 year-follow-up study. Addiction. 2015;110(11):1794–802. doi: 10.1111/add.13042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Moffitt TE. Cannabis use in adolescence and risk for adult psychosis: Longitudinal prospective study. BMJ. 2002;325(7374):1212–13. doi: 10.1136/bmj.325.7374.1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hawkins JD, Catalano RF, Miller JY. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: Implications for substance abuse prevention. Psychol Bull. 1992;112(1):64–105. doi: 10.1037/0033-2909.112.1.64. [DOI] [PubMed] [Google Scholar]
  • 29.The Daily - Table 1 Police-reported Crime for Selected Offences, Canada [homepage on the Internet]. Ottawa, ON: Statistics Canada, 2014. Available at: http://www.statcan.gc.ca/daily-quotidien/140723/tl40723b001-eng.htm (Accessed August 5, 2015).
  • 30.Rehm J, Gnam W, Popova S, Baliunas D, Brochu S, Fischer B, et al. The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. J Stud Alcohol Drugs. 2007;68(6):886–95. doi: 10.15288/jsad.2007.68.886. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Journal of Public Health = Revue Canadienne de Santé Publique are provided here courtesy of Springer

RESOURCES